Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats

Diabetes

Volumn 48, Issue 12, 1999, Pages 2270-2276

  Xu, Gang ^a   Stoffers, Doris A ^b   Habener, Joel F ^b   Bonner Weir, Susan ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HYPERGLYCEMIA; INNER CELL MASS; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS RESECTION; PRIORITY JOURNAL; RAT; STEM CELL;

EID: 0033513455     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.12.2270     Document Type: Article

References (31)

1. Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU: Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Sun Synth Pathol Res 4:110-125, 1985
2. Weir GC, Bonner-Weir S, Leahy JL: Islet mass and function in diabetes and transplantation. Diabetes 39:401-405, 1980
3. Smith FE, Rosen KM, Villa-Komaroff L, Weir GC, Bonner-Weir S: Enhanced insulin-like growth factor I gene expression in the regenerating rat pancreas. Proc Natl Acad Sci U S A 88:6152-6156, 1991
4. Rosenberg L, Vinik AI, Pittenger GL, Rafaeloff R, Duguid WP: Islet-cell regeneration in the diabetic hamster pancreas with restoration of normoglycemia can be induced by a local growth factor(s). Diabetologia 39:256-262, 1996
5. Edvell A, Lindstrom P: Initiation of increased pancreatic islet growth in young normoglycemic mice (Uraea +/?). Endocrinology 140:778-783, 1999
6. Gu D, Lee MS, Krahl T, Sarvetnick N: Transitional cells in the regenerating pancreas. Development 120:1873-1881, 1994
7. Mojsov S, Weir GC, Habener JF: Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79:616-619, 1987
8. Gutniak M, Orskov C, Holst JJ, Ahren B, Efendic S: Antidiabetogenic effect of glucagon-like peptide 1 (7-36) amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326:1316-1322, 1992
9. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W: Preserved incretin activity of glucagon-like peptide I (7-36) amide but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 91:301-307, 1993
10. Thorens B, Porret A, Bühler L, Deng S-P, Morel P, Widmann C: Cloning and functional expression of the human islet GLP-I receptor demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. Diabetes 42:1678-1682, 1993
11. Wang Y, Perfetti R, Greig N, Holloway H, DeOre K, Montrose-Rafizadeh C, Elahi D, Egan JM: Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats. J Clin Invest 99:2883-2889, 1997
12. Chen YE, Drucker DJ: Tissue-specific expression of unique mRNA that encode pro-glucagon-derived peptides or exendin 4 in the lizard. J Biol Chem 272:4108-4115, 1997
13. Goke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Goke B: Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. J Biol Chem 15:19650-19655, 1993
14. Greig NH, Holloway HN, DeOre KA, Jani D, Wang Y, Zhou J, Garant MJ, Egan JM: Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations. Diabetologia 42:45-50, 1999
15. Bonner-Weir S, Trent DF, Weir GC: Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J Clin Invest 71:1544-1553, 1983
16. Montana E, Bonner-Weir S, Weir GC: Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin-diabetic C57BL/6 mice. J Clin Invest 91:780-787, 1993
17. Sharma A, Zangen DH, Reitz P, Taneja M, Lissauer ME, Miller CP, Weir GC, Habener JF, Bonner-Weir S: The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes 48:507-513, 1999
18. Heller RS, Kieffer TJ, Habener JF: Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas. Diabetes 46:785-791, 1997
19. Jonas J-C, Sharma A, Hasenkamp W, Ilkova H, Patane G, Laybutt R, Bonner-Weir S, Weir GC: Chronic hyperglycemia and loss of β cell differentiation. J Biol Chem 274:14112-14121, 1999
20. Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE: A second pathway for regeneration of the adult exocrine and endocrine pancreas: a possible recapitulation of embryonic development. Diabetes 42:1715-1720, 1993
21. Horsch D, Goke R, Eissele R, Michel B, Goke B: Reciprocal cellular distribution of glucagon-like peptide-1 (GLP-1) immunoreactivity and GLP-1 receptor mRNA in pancreatic islets of rat. Pancreas 14:290-294, 1997
22. Holz GG, Kuhtreiber WM, Habener JF: Pancreatic beta-cells are rendered glucose-competent by insulinotropic hormone glueagon-like peptide. Nature 361:362-365, 1993
23. Holst JJ: Glucagonlike peptide 1, a newly discovered gastrointestinal hormone. Gastroenterology 107:1048-1055, 1994
24. Scrocchi LA, Brown TJ, MaClusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ: Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2:1254-1258, 1996
25. Scrocchi LA, Marshall BA, Cook SM, Brubaker PL, Drucker DJ: Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling. Diabetes 47:632-639, 1998
26. Drucker DJ, Deforest L, Brubaker PL: Intestinal response to growth factors administered alone or in combination with human [Gly2] glucagon-like peptide 2. Am J Physiol 273:G1252-G1262, 1997
27. Drucker DJ, Ehrlich P, Asa SL, Brubaker PL: Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A 93:7911-7916, 1996
28. Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF: Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci U S A 84:3434-3438, 1987
29. Unger RH, Aguilar-Parada E, Muller WA, Eisentraut AM: Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest 49:837-848, 1970
30. Dobbs R, Sakurai H, Saski H, Faloona GR, Valverde I, Baetens D, Orci L, Unger R: Glucagon: role in the hyperglycemia of diabetes mellitus. Science 187:544-547, 1975
31. O'Reilly LA, Gu D, Sarvetnick N, Edlund H, Phillips JM, Fulford T, Cooke A: α-Cell neogenesis in an animal model of IDDM. Diabetes 46:599-606, 1997